{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-012130","form_type":"8-K","ticker":"NXTS","cik":"0001789192","company_name":"Nexentis Technologies Inc.","filed_at":"2025-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.000374+00:00","generated_at":"2026-05-17T11:59:30.216752+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"N2OFF (NITO) provides $372K bridge loan to MitoCareX Bio pending acquisition","bullets":["Loan principal $372,000 from N2OFF to MitoCareX Bio Ltd., term 6 months, interest at Israel Tax Authority USD rate +3%.","Disbursement in three tranches: $200K at signing, $86K on Sep 15, 2025, $86K on Oct 15, 2025.","L.I.A. Pure Capital Ltd. guarantees full repayment of principal and interest.","If acquisition closes, outstanding loan amount deducted from first-year allocation to MitoCareX.","Loan supports MitoCareX's ongoing costs until acquisition stockholder approval and closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-012130","json":"https://secwatch.observer/filing/0001493152-25-012130.json","markdown":"https://secwatch.observer/filing/0001493152-25-012130.md","text":"https://secwatch.observer/filing/0001493152-25-012130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789192/000149315225012130/0001493152-25-012130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789192/000149315225012130/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T11:59:30.216752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}